Selex Galileo to develop Owlstone products

Nanotechnology company Owlstone has entered into an exclusive strategic development agreement with Selex Galileo, a European aerospace and defence organisation.

Under the agreement, Selex will obtain the exclusive right to develop and distribute Owlstone’s FAIMS chemical-detection technology products within the military marketplace.

The initial agreement is for a period of 12 months.